OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lirentelimab for severe and chronic forms of allergic conjunctivitis
Stephen D. Anesi, Joseph Tauber, Quan Dong Nguyen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 3, pp. 631-639
Open Access | Times Cited: 35

Showing 26-50 of 35 citing articles:

Unraveling the complexity – Insights and interventions of refractory vernal keratoconjunctivitis
Shweta Agarwal, Serge Doan, Bhaskar Srinivasan, et al.
The Ocular Surface (2024) Vol. 34, pp. 173-182
Open Access | Times Cited: 1

Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment
Erminia Ridolo, Francesca Nicoletta, Carlo Lombardi, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 10, pp. 100968-100968
Open Access | Times Cited: 1

Omalizumab for severe allergic keratoconjunctivitis: A case series
Marie Mercier, Serge Doan, Imane Elaouane, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 11, pp. 3528-3530
Closed Access | Times Cited: 3

Efficacy of topical cyclosporine 0.5% in vernal keratoconjuctivitis.
Amber Khalid, Kanwal Zehra Rizvi, Qurat‐ul‐Ain, et al.
The Professional Medical Journal (2024) Vol. 31, Iss. 04, pp. 607-612
Open Access

Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals
Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 208-222
Open Access

Development of a Temperature and pH Dual-Sensitive In-Situ Gel for Treating Allergic Conjunctivitis
Yanpeng Zhu, Yinghui Liu, Yongyue Wang, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access

Monoclonal antibodies in phase II and III trials for moderate to severe atopic dermatitis
Heli A. Patel, Linh Tran, Ralina Karagenova, et al.
Expert Opinion on Emerging Drugs (2024), pp. 1-8
Closed Access

Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders
Sheryl Y. T. Lim, Jenny Huo, George S. Laszlo, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3476-3476
Open Access

Mechanism of PM2.5 Induced/Aggravated Allergic Diseases and its Prevention and Treatment
Xinmeng Wang, Mengyuan Xu, Miaomiao Xu, et al.
Allergy medicine. (2024) Vol. 2, pp. 100012-100012
Open Access

Vectorized Human Antibody-Mediated Anti-Eosinophil Gene Therapy
Maria Gioulvanidou, Selenay S. Sarklioglu, Xinlei Chen, et al.
Human Gene Therapy (2024)
Closed Access

Previous Page - Page 2

Scroll to top